Cytokinetics EVP R&D Malik Fady Ibraham disposes of 3,500 common shares valued at $214,830

PUBT · 2d ago
Cytokinetics EVP R&D Malik Fady Ibraham disposes of 3,500 common shares valued at $214,830
  • Malik Fady Ibraham, EVP of Research & Development at Cytokinetics, reported a same-day option exercise and stock sale on Oct. 6, 2026.
  • Exercised 3,500 common shares at USD 7.8 per share.
  • Sold 3,500 common shares at USD 61.38 per share.
  • Directly held 153,902 common shares following the transactions.
  • Directly held 19,886 non-qualified stock options following the exercise.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytokinetics Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001061983-26-000098), on October 06, 2026, and is solely responsible for the information contained therein.